[Etofibrate and clofibrate in a double-blind trial on patients with raised serum-lipid levels (author's transl)].
In a clinical trial of 21 patients with hypercholesteraemia and (or) hypertriglyceridaemia, the effects of etofibrate and clofibrate were compared with one another and against a placebo: both drugs lowered triglyceride levels significantly, but etofibrate also had a stronger cholesterol-lowering effect. Both substances were well tolerated.